Overdose how excessive government regulation stifles pharmaceutical innovation
Contributor(s): Yale University Institute for Policy Innovation.Material type: BookPublisher: New Haven Yale University Press 2006Description: xi, 283 p. 25 cm.ISBN: 9780300116649.Subject(s): United States--Food and Drug Administration | Pharmaceutical industry -- Government policy -- United States | Drug Industry -- United States | Government Regulation -- United States | Public Policy -- United StatesDDC classification: 338.4761510973
|Item type||Current location||Call number||Status||Date due||Barcode|
|Books||O. P. Jindal Global University Library||338.4761510973 EP-O (Browse shelf)||Available||016063|
"An Institute for Policy Innovation Book."
Includes bibliographical references (p. 241-271) and index.
Rising expectations-- and diminishing returns -- Property generally : externalities, coordination, and the public domain -- Intellectual property: the public domain and private rights -- Taming conflict of interests -- Federally sponsored research under Bayh-Dole -- The anticommons -- The single monopoly : current patent limitations -- Rate regulation : an unneeded swamp -- Patent purchases: a second swamp -- Socialization of R & D : the final swamp -- The steady expansion of FDA power -- FDA versus the individual : upstream or downstream decision making -- Drug withdrawal : too much, too soon -- Getting the drugs to market -- Deceptive marketing -- Tort preliminaries -- Product liability for prescription drugs : manufacturing and design cases -- The main event : misrepresentation, overpromotion, and duty to warn -- Conclusion : socialized medicines.